Products
-
FOB Rapid Test
REF 501060 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Cervical/urethra swab Intended Use The StrongStep® FOB Rapid Test Device (Feces) is a rapid visual immunoassay for the qualitative presumptive detection of human hemoglobin in human fecal specimens. -
Fungal fluorescence staining solution
REF 500180 Specification 100 Tests/Box; 200 Tests/Box Detection principle One step Specimens Dandruff / Nail shaving / BAL / Tissue smear / Pathological section, etc Intended Use StrongStep® Fetal Fibronectin Rapid Test is a visually interpreted immunochromatographic test intended to be used for the qualitative detection of fetal fibronectin in cervicovaginal secretions. The FungusClearTM Fungal fluorescence staining solution is used for the rapid Identification of various fungal infections in human fresh or frozen clinical specimens, paraffin or glycol methacrylate embedded tissues. Typical specimens include scraping, nail and hair of dermatophytosis such as tinea cruris, tinea manus and pedis, tinea unguium, tinea capitis, tinea versicolor. Also include sputum, bronchoalveolar lavage(BAL), bronchial wash, and tissue biopsies from invasive fungal infection patients.
-
Dual Biosafety System Device for SARS-CoV-2 Antigen Rapid Test
REF 500210 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Nasal / Oropharyngeal swab Intended Use This is a rapid immunochromatographic assay for the detection of SARS-CoV-2 virus Nucleocapsid Protein antigen in human Nasal /Oropharyngeal swab collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The assay is used as an aid in the diagnosis of COVID-19. -
Novel Coronavirus (SARS-CoV-2) Multiplex Real-Time PCR Kit
REF 500190 Specification 96 Tests/Box Detection principle PCR Specimens Nasal / Nasopharyngeal swab Intended Use This is intended to be used to achieve qualitative detection of SARS-CoV-2 viral RNA extracted from nasopharyngeal swabs, oropharyngeal swabs, sputum and BALF from patients in association with an FDA/CE IVD extraction system and the designated PCR platforms listed above. The kit is intended for use by laboratory trained personnel
-
SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit
REF 510010 Specification 96 Tests/Box Detection principle PCR Specimens Nasal / Nasopharyngeal swab / Oropharyngeal swab Intended Use StrongStep® SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is intended for simultaneous qualitative detection and differentiation of SARS-CoV-2,Influenza A virus and Influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab or oropharyngeal swab specimens and self-collected nasal or oropharyngeal swab specimens(collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider.
The kit is intended for use by laboratory trained personnel
-
Vibrio cholerae O1 Antigen Rapid Test
REF 501050 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Feces Intended Use The StrongStep® Vibrio cholerae O1 Antigen Rapid Test Device (Feces) is a rapid visual immunoassay for the qualitative, presumptive detection of Vibrio cholerae O1 in human fecal specimens. This kit is intended for use as an aid in the diagnosis of Vibrio cholerae O1 infection. -
Bacterial vaginosis Rapid Test
REF 500080 Specification 50 Tests/Box Detection principle PH value Specimens Vaginal discharge Intended Use The StrongStep® Bacterial vaginosis(BV) Rapid Test Device is intend to measure the vaginal pH for aid in the diagnosis of Bacterial vaginosis. -
Procalcitonin Test
REF 502050 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Plasma / Serum / Whole blood Intended Use The StrongStep® Procalcitonin Test is a rapid immune-chromatographic assay for the semi-quantitative detection of Procalcitonin in human serum or plasma. It is used for diagnosing and controlling the treatment of severe, bacterial infection and sepsis. -
SARS-CoV-2 IgM/IgG Antibody Rapid Test
REF 502090 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Whole Blood / Serum / Plasma Intended Use This is a rapid immuno-chromatographic assay for the simultaneous detection of IgM and IgG antibodies to SARS-CoV-2 virus in human whole blood, serum or plasma. The test is limited in the US to distribution to laboratories certified by CLIA to perform high complexity testing.
This test has not been reviewed by the FDA.
Negative results do not preclude acute SARS-CoV-2 infection.
Results from antibody testing should not be used to diagnose or exclude acute SARS-CoV-2 infection.
Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
-
Neisseria gonorrhoeae/Chlamydia trachomatis Antigen Combo Rapid Test
REF 500050 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Cervical/urethra swab
Intended Use This is a rapid lateral-flow immunoassay for the qualitative presumptive detection of Neisseria gonorrhoeae/Chlamydia trachomatis antigens in male urethral and female cervical swab -
Neisseria Gonorrhoeae Antigen Rapid Test
REF 500020 Specification 20 Tests/Box Detection principle Immunochromatographic assay Specimens Cervical/urethra swab Intended Use It is suitable for qualitative detection of gonorrhoea/chlamydia trachomatis antigens in cervical secretions of women and urethral samples of men in vitro in various medical institutions for auxiliary diagnosis of the above pathogen infection. -
Cryptococcal Antigen Rapid Test Device
REF 502080 Specification 20 Tests/Box; 50 Tests/Box Detection principle Immunochromatographic assay Specimens Cerebrospinal fluid/Serum Intended Use StrongStep®Cryptococcal Antigen Rapid Test Device is a rapid immune-chromatographic assay for the detection of the capsular polysaccharide antigens of Cryptococcus species complex (Cryptococcus neoformans and Cryptococcus gattii) in serum,plasma, whole blood and cerebral spinal fluid (CSF)
